Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
41–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of COPD for at least 2 years based on American Thoracic Society/European Respiratory Society (ATS/ERS) current guidelines or symptoms consistent with COPD for at least 2 years.
\>40 to \<=75 years of age, of either sex, and of any race.
No exacerbation or respiratory infection in the past 6 weeks.
Smoker or ex-smoker with more than 10 pack-year history.
You may not be if
Diagnosis of asthma or other clinically relevant lung disease (other than COPD), i.e., sarcoidosis, tuberculosis, pulmonary fibrosis, severe bronchiectasis, or lung cancer.
Significant X-ray findings.
Use of supplemental oxygen for \>12 hours/day.
Clareo Health | Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019)
